Virologic Response Rates of Telaprevir-based Hepatitis C Triple Therapy in Patients with and without HIV Co-infection

OBJECTIVES: Pegylated-interferon/ribavirin dual therapy for hepatitis C virus (HCV) has a lower sustained virologic response (SVR) rate in HIV/HCV-co-infected patients than in HCV mono-infected patients, but little is known about the relative effectiveness of teleprevir-based triple therapy in the t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Martel-Laferrière, V, Brinkley, S, Bichoupan, K, Posner, S, Stivala, A, Perumalswami, P, Schiano, TD, Sulkowski, M, Dieterich, DT, Branch, AD
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947307/
https://ncbi.nlm.nih.gov/pubmed/24025147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12086
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller